期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

分子靶向治疗药物的研究进展 被引量：5

Research Progress in Molecular Targeted Therapy
原文传递
导出
摘要 分子靶向药物治疗已逐渐成为肿瘤标准治疗的一部分。目前已有20多种分子靶向药物获批上市,在研药物多达100余种。文章对分子靶向药物的研究进展作一综述。
作者 刘端祺 战淑君
机构地区 中国人民解放军北京军区总医院肿瘤中心
出处 《中国肿瘤》 CAS 2008年第11期942-944,共3页 China Cancer
关键词 肿瘤 分子靶向 药物治疗
分类号 R730.5 [医药卫生—肿瘤]
  • 相关文献

参考文献11

  • 1刘端祺.关注肿瘤治疗的新进展[J].解放军医学杂志,2007,32(7):661-663. 被引量：3
  • 2Milano A,De Rosa V,Iaffaioli RV, et al. Downstream intracellular effeetors of epidermal growth factor receptor as targets for anticaneer therapy [J]. Expert Opin Ther Targets, 2007, 11(6):771-782.
  • 3Tabernero J.The role of VEGF and EGFR inhibition:implications for combining anti-VEGF and anti-EGFR agents[J]. Mol Cancer Res, 2007, 5(3):203-220.
  • 4Duda DG, Batchelor TT, Willett CG, et al. VEGF-targeted cancer therapy strategies: current progress, hurdles and future prospects[J]. Trends Mol Med, 2007,13(6):223-230.
  • 5Liu L,Cao Y,Chen C,et al.Sorafenib blocks the RAF/MEK/ ERK pathway, inhibits tumor angiogenesis, and induces tumor cell apoptosis in hepatocellular carcinoma model PLC/PRF/5[J]. Cancer Res, 2006, 66(24):11851.
  • 6Weiner LM,Borghaei H.Targeted therapies in solid tumors: Monoclonal antibodies and small molecules [J]. Human Antibodies, 2006, 15(3): 103-111.
  • 7Suzuki R, Rao PI Sasaguri S. Current status and future of target-based therapeutics [J]. Curr Cancer Drug Targets, 2007, 7(3):273-284.
  • 8Meyerhardt J, Stuart K, Fuchs C, et al. Cancer drug trials show modest benefit: drugs target liver, gastric, head and neck cancers[J]. JAMA, 2007, 298(3):273-275.
  • 9Meyerhardt J, Stuart K, Fuchs C, et al. Phase Ⅱ study of FOLFOX, bevacizumab and erlotinib as first-line therapy for patients with metastastic colorectal cancer[J]. Ann Oncol, 2007, 18(7):1185-1189.
  • 10Geyer CE, Forster J, Lindquist D, et al. Lapatinib plus capecitabine for HER2-positive advanced breast cancer[J]. N Engl J Med, 2006, 55(26):2733.

二级参考文献8

  • 1李建华.对军队疾控机构建设与发展的思考[J].解放军医学杂志,2007,32(2):85-87. 被引量：4
  • 2Suzuki R,Rao P,Sasaguri S.Current status and future of target-based therapeutics.Curr Cancer Drug Targets,2007,7(3):273.
  • 3Guillemard V,Saragovi HU.Novel approaches for targeted cancer therapy,2004,4(4):313.
  • 4Veronesi U.Breast cancer:a look to the future,The 26th Annual SAN ANTONIO Breast CancerSymposium[EB/OL].[2003-12-4]http://www.springerlink.com/content/n58503l5m34433r7/?p=3e701fe5f7ed4802a24799b379e06418&pi=1.
  • 5Luini A,Gatti G,Galimberti V,et al.Conservative treatment of breast cancer:its evolution.Breast Cancer Res Treat,2005,94(3):195.
  • 6Galvin JM,De Neve W.Intensity modulating and other radiation therapy devices for dose painting.J Clin Oncol,2007,25(8):924.
  • 7Pedrazzoli P,Ledermann JA,Lotz JP,et al.High dose chemotherapy with autologous hematopoietic stem cell support for solid tumors other than breast cancer in adults.Ann Oncol,2006,17(10):1479.
  • 8Johnson JR,Williams G,Pazdur R.End Points and United States Food and Drug Administration approval of oncology drug.Clinical Oncology,2003,21(7):1401.

共引文献2

同被引文献41

引证文献5

二级引证文献28

中国肿瘤
2008年 第11期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部